{"seq": 1, "variant": "control", "cmd": "pm --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm - PubMed CLI tools for AI agents\n\nUsage: pm <command> [OPTIONS]\n\nCommands:\n  init        Initialize audit trail and cache (.pm/)\n  search      Search PubMed, return PMIDs\n  fetch       Fetch PubMed XML by PMIDs\n  parse       Parse PubMed XML to JSONL\n  filter      Filter JSONL articles by field patterns\n  cite        Fetch CSL-JSON citations\n  download    Download full-text PDFs\n  diff        Compare two JSONL files by PMID\n  audit       View audit trail and PRISMA report\n  quick       One-command search pipeline (outputs JSONL)\n\nExamples:\n  pm search \"CRISPR cancer\" | pm fetch | pm parse > results.jsonl\n  pm quick \"covid vaccine\" --max 50\n  pm filter --year 2024 --has-abstract < articles.jsonl\n\nUse 'pm <command> --help' for command-specific help.\n", "stderr": "", "elapsed_s": 0.247, "ts": 1771594435.0953863}
{"seq": 2, "variant": "control", "cmd": "pm search --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm search - Search PubMed and return PMIDs\n\nUsage: pm search [OPTIONS] \"search query\"\n\nOptions:\n  --max N        Maximum results to return (default: 10000)\n  --refresh      Bypass cache and re-fetch from PubMed\n  -h, --help     Show this help message\n\nOutput:\n  PMIDs to stdout, one per line\n\nExamples:\n  pm search \"CRISPR cancer therapy\"\n  pm search --max 100 \"machine learning\"\n  pm search \"covid vaccine 2024\" | pm fetch | pm parse > results.jsonl\n\nQuery syntax:\n  Uses PubMed query syntax. See:\n  https://pubmed.ncbi.nlm.nih.gov/help/#search-tags\n", "stderr": "", "elapsed_s": 0.359, "ts": 1771594444.6771448}
{"seq": 3, "variant": "control", "cmd": "pm fetch --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm fetch - Fetch PubMed XML from E-utilities API\n\nUsage: echo \"12345\" | pm fetch > articles.xml\n       cat pmids.txt | pm fetch > articles.xml\n\nOptions:\n  -v, --verbose  Show progress on stderr\n  -h, --help     Show this help message\n\nInput:\n  PMIDs from stdin, one per line\n\nOutput:\n  PubMed XML to stdout\n\nFeatures:\n  - Batches requests (200 PMIDs per API call)\n  - Rate limits to ~3 requests/second\n  - Exits with error on network failure\n\nExamples:\n  echo \"12345\" | pm fetch > article.xml\n  cat pmids.txt | pm fetch > articles.xml\n  pm search \"CRISPR\" | pm fetch | pm parse > results.jsonl\n", "stderr": "", "elapsed_s": 0.263, "ts": 1771594449.557419}
{"seq": 4, "variant": "control", "cmd": "pm parse --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm parse - Parse PubMed XML to JSONL\n\nUsage: cat articles.xml | pm parse [OPTIONS] > articles.jsonl\n       zcat articles.xml.gz | pm parse [OPTIONS] > articles.jsonl\n\nOptions:\n  -v, --verbose  Show progress on stderr\n  -h, --help     Show this help message\n\nOutput:\n  One JSON object per line (JSONL format) with fields:\n    pmid, title, authors, journal, year, date, doi, pmcid, abstract\n\nExamples:\n  cat pubmed.xml | pm parse > articles.jsonl\n  zcat pubmed25n0001.xml.gz | pm parse > articles.jsonl\n  cat pubmed.xml | pm parse --verbose > articles.jsonl 2>progress.log\n", "stderr": "", "elapsed_s": 0.283, "ts": 1771594455.4070706}
{"seq": 5, "variant": "control", "cmd": "pm filter --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm filter - Filter JSONL articles by field patterns\n\nUsage: pm parse | pm filter [OPTIONS]\n       cat articles.jsonl | pm filter [OPTIONS]\n\nFilter Options:\n  --year PATTERN      Year filter (exact, range, or open-ended)\n                      Examples: 2024, 2020-2024, 2020-, -2024\n  --journal PATTERN   Journal contains PATTERN (case-insensitive)\n  --journal-exact STR Journal equals STR exactly\n  --author PATTERN    Any author contains PATTERN (case-insensitive)\n  --has-abstract      Article has non-empty abstract\n  --has-doi           Article has DOI\n\nGeneral Options:\n  -v, --verbose       Show filter stats on stderr\n  -h, --help          Show this help\n\nExamples:\n  pm filter --year 2020- --journal nature --has-abstract\n  pm filter --author smith\n  pm filter --year 2020-2024\n\nNotes:\n  - Multiple filters combine with AND logic\n  - Malformed JSON lines are silently skipped\n", "stderr": "", "elapsed_s": 0.348, "ts": 1771594460.974938}
{"seq": 6, "variant": "control", "cmd": "pm quick --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm quick - Quick PubMed search (outputs JSONL)\n\nUsage: pm quick [OPTIONS] \"search query\"\n\nOptions:\n  --max N         Maximum results (default: 100)\n  -v, --verbose   Show progress on stderr\n  -h, --help      Show this help message\n\nOutput:\n  JSONL to stdout (one article per line)\n\nExamples:\n  pm quick \"CRISPR cancer therapy\"\n  pm quick --max 20 \"machine learning diagnosis\"\n\nFor advanced filtering, use the full pipeline:\n  pm search \"query\" | pm fetch | pm parse | pm filter --year 2024\n", "stderr": "", "elapsed_s": 0.273, "ts": 1771594466.9864776}
{"seq": 7, "variant": "control", "cmd": "pm init", "exit_code": 0, "stdin_lines": 0, "stdout": "Initialized .pm/ in /home/user/pm-tools/e2e/workdirs/ab4-control-topic1\nAudit trail: .pm/audit.jsonl\nCache: .pm/cache/\n", "stderr": "", "elapsed_s": 0.225, "ts": 1771594491.3844004}
{"seq": 8, "variant": "control", "cmd": "pm search FES PET lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "", "elapsed_s": 0.674, "ts": 1771594501.4775636}
{"seq": 9, "variant": "control", "cmd": "pm search fluoroestradiol PET lobular breast", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40813238\n40761268\n40369385\n40035673\n39438056\n39385362\n39058489\n38365547\n38117098\n36919879\n36879065\n36243494\n36083216\n35681669\n34643778\n32680923\n28604479\n27607175\n17515338\n", "stderr": "", "elapsed_s": 0.867, "ts": 1771594511.340506}
{"seq": 10, "variant": "control", "cmd": "pm search 16alpha-fluoroestradiol PET breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "39368910\n11337559\n10708304\n", "stderr": "", "elapsed_s": 0.883, "ts": 1771594521.067988}
{"seq": 11, "variant": "control", "cmd": "pm search FES PET breast cancer estrogen receptor imaging", "exit_code": 0, "stdin_lines": 0, "stdout": "41532824\n41344861\n41319353\n41275454\n41275453\n41186678\n40976009\n40968016\n40813238\n40791606\n40761268\n40682675\n40569557\n40539912\n40474373\n40427142\n40369385\n40179297\n40179295\n40127051\n40081952\n40035673\n39962532\n39848768\n39806206\n39613672\n39506820\n39440077\n39423781\n39385365\n39368910\n39362758\n39123367\n39058489\n38993095\n38929989\n38743917\n38436824\n38427956\n38423389\n38365547\n38117098\n38107829\n38105347\n38071554\n37787851\n37620179\n37566798\n37482660\n37433673\n37296702\n37270377\n37223262\n36988617\n36919879\n36879065\n36863779\n36821506\n36800243\n36735488\n36620595\n36243494\n36093891\n36083216\n36028895\n35884590\n35797633\n35717099\n35675139\n35584346\n35464670\n35448720\n35407526\n35379454\n35362795\n35119664\n35116468\n34988456\n34829366\n34725978\n34545689\n34476181\n34446451\n34392915\n34319950\n34139575\n34031720\n33990400\n33369181\n33354178\n33181752\n32912274\n32859700\n32718075\n32699974\n32680923\n32601772\n32591490\n32448947\n32374053\n32307594\n32272493\n32229068\n32174461\n32111662\n31891878\n31337657\n31281233\n30850489\n30846327\n30833270\n30176563\n30100079\n29956818\n29755845\n29602822\n29488712\n29485433\n29478216\n29466767\n28912144\n28798032\n28747642\n28553180\n28221191\n28011460\n27872957\n27774910\n27607175\n27739102\n27688475\n27467716\n27342400\n27307345\n26850484\n26091705\n25880006\n25693420\n25617853\n25609068\n25520392\n25476421\n25380844\n24170452\n24079874\n23970364\n23787040\n23762549\n23725994\n23619898\n23105956\n22749433\n22669982\n22379639\n22241912\n22079037\n21982568\n21750198\n21204318\n19914546\n20641704\n20641441\n18327670\n18287268\n18250990\n17920354\n17718929\n17499736\n17156828\n16682724\n15246367\n12123788\n11337559\n10708304\n10096512\n9933662\n9800236\n9257333\n9179196\n9816253\n7562040\n1869973\n", "stderr": "", "elapsed_s": 0.974, "ts": 1771594530.3848033}
{"seq": 12, "variant": "control", "cmd": "pm search FES PET invasive lobular carcinoma", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n39438056\n39385362\n38427956\n37239021\n36919879\n35681669\n34545689\n32680923\n28604479\n25693420\n", "stderr": "", "elapsed_s": 0.92, "ts": 1771594540.3783214}
{"seq": 13, "variant": "control", "cmd": "pm search fluoroestradiol positron emission tomography lobular breast", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40813238\n40761268\n40369385\n40035673\n39438056\n39385362\n39058489\n38365547\n38117098\n36919879\n36879065\n36243494\n36083216\n35681669\n32680923\n28604479\n27607175\n17515338\n", "stderr": "", "elapsed_s": 0.664, "ts": 1771594549.5966592}
{"seq": 14, "variant": "control", "cmd": "pm search FES PET lobular breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": "pm: using cached search from 2026-02-20. Use --refresh to update.\n", "elapsed_s": 0.199, "ts": 1771594853.2467768}
{"seq": 15, "variant": "control", "cmd": "pm search FES PET breast cancer estrogen receptor imaging", "exit_code": 0, "stdin_lines": 0, "stdout": "41532824\n41344861\n41319353\n41275454\n41275453\n41186678\n40976009\n40968016\n40813238\n40791606\n40761268\n40682675\n40569557\n40539912\n40474373\n40427142\n40369385\n40179297\n40179295\n40127051\n40081952\n40035673\n39962532\n39848768\n39806206\n39613672\n39506820\n39440077\n39423781\n39385365\n39368910\n39362758\n39123367\n39058489\n38993095\n38929989\n38743917\n38436824\n38427956\n38423389\n38365547\n38117098\n38107829\n38105347\n38071554\n37787851\n37620179\n37566798\n37482660\n37433673\n37296702\n37270377\n37223262\n36988617\n36919879\n36879065\n36863779\n36821506\n36800243\n36735488\n36620595\n36243494\n36093891\n36083216\n36028895\n35884590\n35797633\n35717099\n35675139\n35584346\n35464670\n35448720\n35407526\n35379454\n35362795\n35119664\n35116468\n34988456\n34829366\n34725978\n34545689\n34476181\n34446451\n34392915\n34319950\n34139575\n34031720\n33990400\n33369181\n33354178\n33181752\n32912274\n32859700\n32718075\n32699974\n32680923\n32601772\n32591490\n32448947\n32374053\n32307594\n32272493\n32229068\n32174461\n32111662\n31891878\n31337657\n31281233\n30850489\n30846327\n30833270\n30176563\n30100079\n29956818\n29755845\n29602822\n29488712\n29485433\n29478216\n29466767\n28912144\n28798032\n28747642\n28553180\n28221191\n28011460\n27872957\n27774910\n27607175\n27739102\n27688475\n27467716\n27342400\n27307345\n26850484\n26091705\n25880006\n25693420\n25617853\n25609068\n25520392\n25476421\n25380844\n24170452\n24079874\n23970364\n23787040\n23762549\n23725994\n23619898\n23105956\n22749433\n22669982\n22379639\n22241912\n22079037\n21982568\n21750198\n21204318\n19914546\n20641704\n20641441\n18327670\n18287268\n18250990\n17920354\n17718929\n17499736\n17156828\n16682724\n15246367\n12123788\n11337559\n10708304\n10096512\n9933662\n9800236\n9257333\n9179196\n9816253\n7562040\n1869973\n", "stderr": "pm: using cached search from 2026-02-20. Use --refresh to update.\n", "elapsed_s": 0.199, "ts": 1771594861.760606}
{"seq": 16, "variant": "control", "cmd": "pm search fluoroestradiol PET lobular breast", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40813238\n40761268\n40369385\n40035673\n39438056\n39385362\n39058489\n38365547\n38117098\n36919879\n36879065\n36243494\n36083216\n35681669\n34643778\n32680923\n28604479\n27607175\n17515338\n", "stderr": "pm: using cached search from 2026-02-20. Use --refresh to update.\n", "elapsed_s": 0.211, "ts": 1771594869.7789679}
{"seq": 17, "variant": "control", "cmd": "pm search 16alpha-fluoroestradiol PET breast cancer", "exit_code": 0, "stdin_lines": 0, "stdout": "39368910\n11337559\n10708304\n", "stderr": "pm: using cached search from 2026-02-20. Use --refresh to update.\n", "elapsed_s": 0.223, "ts": 1771594877.342814}
{"seq": 18, "variant": "control", "cmd": "pm search FES PET invasive lobular carcinoma", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n39438056\n39385362\n38427956\n37239021\n36919879\n35681669\n34545689\n32680923\n28604479\n25693420\n", "stderr": "pm: using cached search from 2026-02-20. Use --refresh to update.\n", "elapsed_s": 0.204, "ts": 1771594884.8580904}
{"seq": 19, "variant": "control", "cmd": "pm fetch -v", "exit_code": 0, "stdin_lines": 192, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\"\n \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Manual\"><PMID Version=\"1\">10096512</PMID><DateCompleted><Year>1999</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Print\">0969-8051</ISSN><JournalIssue CitedMedium=\"Print\"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>1999</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nuclear medicine and biology</Title><ISOAbbreviation>Nucl Med Biol</ISOAbbreviation></Journal><ArticleTitle>Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.</ArticleTitle><Pagination><StartPage>123</StartPage><EndPage>130</EndPage><MedlinePgn>123-30</MedlinePgn></Pagination><Abstract><AbstractText>16beta-[18F]Fluoromoxestrol ([18]betaFMOX) is an analog of 16alpha-[18F]fluoroestradiol-17beta ([18F]FES), a radiopharmaceutical known to be an effective positron emission tomography (PET) imaging agent for estrogen receptor-positive (ER+) human breast tumors. Based on comparisons of target tissue uptake efficiency and selectivity in a rat model, [18F]betaFMOX was predicted to be as effective an imaging agent as [18F]FES. However, in a preliminary PET imaging study with [18F]FMOX of 12 patients, 3 of whom had ER+ breast cancer, no tumor localization of [18F]betaFMOX was observed. In search for an explanation for the unsuccessful [18F]betaFMOX clinical trial, we have examined the rate of metabolism of [18F]FMOX and [18F]FES in isolated rat, baboon, and human hepatocytes. We have also studied the effect of the serum protein sex hormone-binding globulin (SHBG), which binds [18F]FES better than [18F]betaFMOX, on these rates of metabolism. Immatur", "stderr": "Fetching batch 1 (192 PMIDs)...\n", "elapsed_s": 2.919, "ts": 1771594902.1767504}
{"seq": 20, "variant": "control", "cmd": "pm parse -v", "exit_code": 0, "stdin_lines": 485, "stdout": "{\"pmid\": \"10096512\", \"title\": \"Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.\", \"authors\": [\"Jonson S D\", \"Bonasera T A\", \"Dehdashti F\", \"Cristel M E\", \"Katzenellenbogen J A\", \"Welch M J\"], \"journal\": \"Nuclear medicine and biology\", \"year\": \"1999\", \"date\": \"1999-01\", \"abstract\": \"16beta-[18F]Fluoromoxestrol ([18]betaFMOX) is an analog of 16alpha-[18F]fluoroestradiol-17beta ([18F]FES), a radiopharmaceutical known to be an effective positron emission tomography (PET) imaging agent for estrogen receptor-positive (ER+) human breast tumors. Based on comparisons of target tissue uptake efficiency and selectivity in a rat model, [18F]betaFMOX was predicted to be as effective an imaging agent as [18F]FES. However, in a preliminary PET imaging study with [18F]FMOX of 12 patients, 3 of whom had ER+ breast cancer, no tumor localization of [18F]betaFMOX was observed. In search for an explanation for the unsuccessful [18F]betaFMOX clinical trial, we have examined the rate of metabolism of [18F]FMOX and [18F]FES in isolated rat, baboon, and human hepatocytes. We have also studied the effect of the serum protein sex hormone-binding globulin (SHBG), which binds [18F]FES better than [18F]betaFMOX, on these rates of metabolism. Immature rat hepatocytes were found to metabolize [18F]FES 31 times faster than [18F]betaFMOX, whereas mature rat cells metabolized [18F]FES only 3 times faster, and baboon and human hepatocytes only 2 times faster than [18F]betaFMOX. In the presence of SHBG, the metabolic consumption rate for [18F]FES in mature rat hepatocytes decreased by 26%. Thus, the very favorable target tissue uptake characteristics of [18F]betaFMOX determined in the rat probably result from its comparative resistance to metabolism (vis-a-vis [18F]FES) in this species, an advantage that is strongly reflected in comparative metabolism rates in rat hepatocytes. In the baboon and human, [18F]FES is extensively protein bo", "stderr": "Parsed article 1: PMID 10096512\nParsed article 2: PMID 10708304\nParsed article 3: PMID 11337559\nParsed article 4: PMID 12123788\nParsed article 5: PMID 15246367\nParsed article 6: PMID 16682724\nParsed article 7: PMID 17156828\nParsed article 8: PMID 17499736\nParsed article 9: PMID 17515338\nParsed article 10: PMID 17718929\nParsed article 11: PMID 17920354\nParsed article 12: PMID 18250990\nParsed article 13: PMID 18287268\nParsed article 14: PMID 18327670\nParsed article 15: PMID 1869973\nParsed article 16: PMID 19914546\nParsed article 17: PMID 21750198\nParsed article 18: PMID 21982568\nParsed article 19: PMID 22079037\nParsed article 20: PMID 22241912\nParsed article 21: PMID 22669982\nParsed article 22: PMID 22749433\nParsed article 23: PMID 23105956\nParsed article 24: PMID 23619898\nParsed article 25: PMID 23725994\nParsed article 26: PMID 23762549\nParsed article 27: PMID 23787040\nParsed article 28: PMID 23970364\nParsed article 29: PMID 24079874\nParsed article 30: PMID 24170452\nParsed article 31: PMID 25380844\nParsed arti", "elapsed_s": 0.315, "ts": 1771594909.9186819}
{"seq": 21, "variant": "control", "cmd": "pm filter --year 2020- --has-abstract -v", "exit_code": 0, "stdin_lines": 188, "stdout": "{\"pmid\": \"31891878\", \"title\": \"Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.\", \"authors\": [\"Boers Jorianne\", \"Venema Clasina M\", \"de Vries Erik F J\", \"Glaudemans Andor W J M\", \"Kwee Thomas C\", \"Schuuring Ed\", \"Martens John W M\", \"Elias Sjoerd G\", \"Hospers Geke A P\", \"Schr\u00f6der Carolina P\"], \"journal\": \"European journal of cancer (Oxford, England : 1990)\", \"year\": \"2020\", \"date\": \"2020-02\", \"abstract\": \"Adding cyclin-dependent kinase (CDK) inhibitor to endocrine treatment improves outcome in \u0153strogen receptor (ER) positive metastatic breast cancer, but identifying the subset of patients who benefit is challenging. Response is potentially associated with ER expression heterogeneity. This is because, unlike the primary tumour in the breast that is localized to the organ, the metastatic breast cancer has spread and continues to spread to distant locations in the body such as bones, lungs, liver, axial skeleton, even to the central nervous system like the brain, wherefrom obtaining biopsies are not easy, and also, the metastasised tissues are heterogeneous. Positron emission tomography (PET) with 16\u03b1-[18F]fluoro-17\u03b2-\u0153stradiol (FES), briefly referred to as FES-PET, allows whole-body ER assessment. We explored whether FES-PET heterogeneity and FES uptake were related to letrozole and palbociclib outcome, in patients with ER positive, metastatic breast cancer. Patients underwent a baseline FES-PET and 18F-fluorodeoxyglucose (FDG) PET, the FDG-PET served to help identify active sites of breast cancer with contrast-enhanced computed tomography (CT). FES-PET heterogeneity score (% FES\u00a0positive\u00a0lesions divided by all lesions on FDG-PET and/or CT) and FES uptake were related to outcome and 8-week FDG-PET response. Circulating tumour DNA (CtDNA) samples for ESR1 mutation analysis were collected at baseline. In 30 patients with 864 metastatic lesions, baseline FES-PET heterogeneity was assessed. In 27 patients with 688 l", "stderr": "110 articles passed filters\n", "elapsed_s": 0.24, "ts": 1771594922.4969158}
